Aristotle University Of Thessaloniki (AUTH)
Μελέτη της βρογχικής υπεραντιδραστικότητας σε ασθενείς με ιδιοπαθή φλεγμονώδη νοσήματα του εντέρου
Abstract
dc:descriptionThe aim of this study was to evaluate bronchial hyperresponsiveness (BHR) in patients with IBD in correlation with the duration, the severity, the extent and the stage (remission or relapse) of the disease, family history, risk factors such as smoking and body mass index (BMI), response to the treatment, drugs used, surgery related to the disease and extraintestinal manifestations. In a prospective study 40 patients aged over 18 with IBD, and 40 subjects used as controls were included. Both groups had to be without heart and pulmonary disease. Patients were evaluated according to sex, age, BMI, smoking and allergic and respiratory disease history. Skin prick tests for ten common allergens were applied to all patients and bronchial hyperresponsiveness was estimated with the use of methacholine challenge test (MC). Results revealed a high frequency of BHR in patients with IBD. Up to 45% were found positive in comparison with only 7,5% of the control group. Also C Reactive Protein and erythrocyte sedimentation rate were significantly higher in patients with IBD. In patients with IBD there was no correlation of the BHR to the duration, the severity, the stage, the extent of the disease, the family history for IBD, the risk factors, the response to the treatment or the drugs used. In addition there was no correlation of the surgical operations and the extraintestinal manifestations with BHR. In the results of skin prick tests there was no significant difference between IBD patients and the control group, but the reaction was more intense in patients with IBD. Comparing ulcerative colitis (UC) patients to patients with Crohn’s disease (CD), there were no differences between the two diseases in all the parameters we evaluated, except the age (patients with CD were younger). It is also noteworthy that patients with CD had been operated more frequently. Evaluation of patients with IBD based on BHR showed that smokers reacted more and that exposure and duration of smoking were a contributing factor. C Reactive Protein was higher in positive MC patients. Extraintestinal manifestations were more in negative to MC patients than in positive patients. All other parameters were no different in the two groups. At this stage our results indicate an increased frequency of bronchial hyperresponsiveness in patients with IBD without clinical manifestations. Bronchial hyperresponsiveness was not related to the duration, the severity, the stage of the disease, the family history for IBD, the BMI, the operations undergone by patients for the disease, the response to the treatment, the drugs used. BHR was related to smoking and increased CRP, in patients with IBD. Extraintestinal manifestations were more in patients negative to MC test. BHR may be considered an extraintestinal manifestation on its own in patients with IBD.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Agorastos, Antonios
- Αγοραστός, Αντώνιος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27616